Please use this identifier to cite or link to this item: http://hdl.handle.net/11455/13276
標題: 犬小病毒重組蛋白VP2的表現及純化
Expression and Purification of recombinant VP2 protein of Canine Parvovirus
作者: 伍子善
Wu, Tzu-San
關鍵字: canine parvovirus
犬小病毒
VP2 protein
VP2蛋白
出版社: 獸醫學系暨研究所
引用: 陳威達。2004。台中地區犬小病毒感染情形及VP1/VP2重組蛋白之表現。碩士論文。國立中興大學獸醫學研究所。台中。台灣。中華民國。 Appel, M. J., Cooper.B.J, Greisen.H, Scott.F., and Carmichael. L.E. 1979. Canine viral enteritis. I. Status report on corona- and parvo-like viral enteritides. J.Am.Vet.Med.Assoc.173:1516-1518. Atwell, R. B., and Kelly. W. R. 1980. Canine parvovirus: a cause of chronic myocardial fibrosis and adolescent congestive heart failure. J.Small Anim Pract. 21:609-20. Battilani,M., Ciulli. S, Tisato. E, and Prosperi. S. 2002. Genetic analysis of canine parvovirus isolates (CPV-2) from dogs in Italy. Virus Res. 26:149-57. Basak, S., and Turner. H. 1992. Infectious entry pathway for canine parvovirus. Virology. 186:368-76. Basak, S., Turner. H, and Parr. S. 1994. Identification of a 40- to 42-kDa attachment polypeptide for canine parvovirus in A72 cells. Virology. 15:7-16. Belak, S., and Ballagi-Pordany A. 1993. Application of the polymerase chain reaction (PCR) in veterinary diagnostic virology. Vet Res Commun. 17:55-72. Binn, L. N., Lazar. E. C, Eddy. G. A, and Kajima. M. 1970. Recovery and Characterization of a Minute Virus of Canines. Infect Immun. 1:503-508. Buonavoglia, C., Tollis. M, Buonavoglia. D, and Puccini. A. 1992 Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine. Comp Immunol Microbiol Infect Dis. 15:281-3. Burtonboy, G., Coignoul. F, Delferriere. N, and Pastoret. P. P. 1979 Canine hemorrhagic enteritis: detection of viral particles by electron microscopy. Arch Virol. 61:1-11. Burtonboy, S., Charlier. P, Hertoghs. J, Lobmann. M, Wiseman. A, and Woods. S. 1991. Performance of high titre attenuated canine parvovirus vaccine in pups with maternally derived antibody. Vet Rec. 20:377-81. Carmichael, L. E. 2005. An annotated historical account of canine parvovirus. J Vet Med B Infect Dis Vet Public Health. 52:303-11. Carmichael, L. E., Schlafer. D. H, and Hashimoto. A. 1991. Pathogenicity of minute virus of canines (MVC) for the canine fetus. Cornell Vet. 81:151-71. Carmichael, L. E., Joubert. J. C, and Pollock. R. V. 1980. Hemagglutination by canine parvovirus: serologic studies and diagnostic applications. Am J Vet Res. 41:784-91. Carmichael, L. E., Joubert. J. C, and Pollock. R. V. 1983. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet. 73:13-29. Casal, J. I., Langeveld. J. P, Cortes. E, Schaaper. W. W, van Dijk. E, Vela. C, Kamstrup. S, and Meloen. R. H. 1995. Peptide vaccine against canine parvovirus: identification of two neutralization subsites in the N terminus of VP2 and optimization of the amino acid sequence. J Virol. 69:7274-7. Chang, W. L., Chang. A.C, and Pan. M. J.1996. Antigenic types of canine parvoviruses prevailing in Taiwan. Vet Rec. 138:447. Cortes, E., San Martin. C, Langeveld. J, Meloen. R, Dalsgaard. K, Vela. C, and Casal. I. 1993. Topographical analysis of canine parvovirus virions and recombinant VP2 capsids. J Gen Virol. 74:5-10. Eugster, A. K. 1980. Studies on canine parvovirus infections: development of an inactivated vaccine. Am J Vet Res. 41:2020-4. Gamoh, K., Shimazaki. Y, Makie. H, Senda. M, Itoh. O, and Inoue. Y. 2003. The pathogenicity of canine parvovirus type-2b, FP84 strain isolated from a domestic cat, in domestic cats. J Vet Med Sci. 65:1027-9. Greenwood, N. M., Chalmers. W. S, Baxendale. W, and Thompson. H. 1995. Comparison of isolates of canine parvovirus by restriction enzyme analysis, and vaccine efficacy against field strains. Vet Rec. 136:63-7. Hayes, M. A., Russell. R. G, and Babiuk. L. A. 1979. Sudden death in young dogs with myocarditis caused by parvovirus. J Am Vet Med Assoc. 174:1197-203. Hirayama, K., Kano. R, Hosokawa-Kanai. T, Tuchiya. K, Tsuyama. S, Nakamura. Y, Sasaki. Y, and Hasegawa. A. 2005. VP2 gene of a canine parvovirus isolate from stool of a puppy. J Vet Med Sci. 67:139-43. Hoare, C. M., DeBouck. P, and Wiseman. A. 1997. Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies. Vaccine. 15:273-5. Hueffer, K., and Parrish. C. R. 2003. Parvovirus host range, cell tropism and evolution. Curr. Opin. Microbiol. 6:392–398. Hueffer, K., Truyen. U, and Parrish C. R. 2004. Evolution and host variation of the canine parvovirus: molecular basis for the development of a new virus. Berl Munch Tierarztl Wochenschr. 117:130-5. [Article in German] Ikeda, Y., M. Mochizuki, R. Naito, K. Nakamura, T. Myazawa, T. Mikami, and E. Takahashi. 2000. Predominance of canine parvovirus (CPV) in unvaccinated cat populations and emergence of new antigenic types of CPVs in cats. Virology. 278: 13–19. Ikeda, Y., Nakamura. K, Miyazawa. T, Takahashi. E, and Mochizuki. M. 2002. Feline host range of canine parvovirus: recent emergence of new antigenic types in cats. Emerg Infect Dis. 8:341-6. Ishiwata, K., Minagawa. T, and Kajimoto. T. 1998. Clinical effects of the recombinant feline interferon-omega on experimental parvovirus infection in beagle dogs. J Vet Med Sci. 60:911-7. Jiang, W., Baker. H. J, Swango. L. J, Schorr. J, Self. M. J, and Smith. B. F. 1998. Nucleic acid immunization protects dogs against challenge with virulent canine parvovirus. Vaccine. 16:601-7. Krakowka, S., Olsen. R. G, Axthelm. M. K, Rice. J, and Winters. K. 1982. Canine parvovirus infection potentiates canine distemper encephalitis attributable to modified live-virus vaccine. J Am Vet Med Assoc. 180:137-9. Langeveld, J. P., Casal. J. I, Vela. C, Dalsgaard. K, Smale. S. H, Puijk. W. C, and Meloen. R. H. 1993. B-cell epitopes of canine parvovirus: distribution on the primary structure and exposure on the viral surface. J Virol. 67:765-72. Lenghaus, C., and Studdert. M. J.1982. Generalized parvovirus disease in neonatal pups. J Am Vet Med Assoc. 181:41-5. Lenghaus, C., Studdert. M. J, and Finnie. J. W. 1980. Acute and chronic canine parvovirus myocarditis following intrauterine inoculation. Aust Vet J. 56:465-8. Lopez de Turiso, J. A., Cortes. E, Ranz. A, Garcia. J, Sanz. A, Vela. C, and Casal JI. 1991. Fine mapping of canine parvovirus B cell epitopes. J Gen Virol. 72:2445-56. Lopez de Turiso, J. A., Cortes. E, Martinez. C, Ruiz de Ybanez. R, Simarro. I, Vela. C, and Casal .I. 1992. Recombinant vaccine for canine parvovirus in dogs. J Virol. 66:2748-53. Lukashov, V. V., and Goudsmit. J. 2001. Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses. J Virol. 75:2729-40. Martella, V., Decaro. N, Elia. G, and Buonavoglia. C. 2005. Surveillance activity for canine parvovirus in Italy. J Vet Med B Infect Dis Vet Public Health. 52:312-5. Macartney, L., Mc. Candlish. I. A, Thompson. H, and Cornwell. H. J. 1984. Canine parvovirus enteritis 1: Clinical, haematological and pathological features of experimental infection. Vet Rec. 115:201-10. Macartney, L., Mc. Candlish. I. A, Thompson. H, and Cornwell. H. J. 1984. Canine parvovirus enteritis 2: Pathogenesis. Vet Rec.115:453-60. Macartney, L., Mc. Candlish. I. A, Thompson. H, and Cornwell. H. J. 1984. Canine parvovirus enteritis 3: Scanning electron microscopical features of experimental infection. Vet Rec. 115:533-7. Maija, Vihinen-Ranta., Dai. Wang, Wendy. S. Weichert, and Colin. R. Parrish. 2002. The VP1 N-Terminal Sequence of Canine Parvovirus Affects Nuclear Transport of Capsids and Efficient Cell Infection J Virol. 76: 1884–1891. Macartney, L., Parrish. C. R, Binn. L. N, and Carmichael . L. E. 1988. Characterization of minute virus of canines (MVC) and its pathogenicity for pups. Cornell Vet. 78:131-45. Marsh, M., and Helenius. A. 1989. Virus entry into animal cells. Adv Virus Res. 36:107-51. Martella, V., Cavalli. A, Pratelli. A, Bozzo. G, Camero. M, Buonavoglia. D, Narcisi. D, Tempesta. M, and Buonavoglia. C. 2004. A Canine Parvovirus Mutant Is Spreading in Italy. J Clin Microbiol. 42:1333-1336. Martella, V., Cavalli. A, Pratelli. A, Bozzo. G, Camero. M, Buonavoglia. D, Narcisi. D, Tempesta. M, and Buonavoglia. C. 2004. Treatment of canine parvoviral enteritis with interferon-omega in a placebo-controlled challenge trial. J Clin Microbiol. 42:1333-1336. Martyn, J.C., Davidson. B. E, and Studdert. M. J. 1990. Nucleotide sequence of feline panleukopenia virus: comparison with canine parvovirus identifies host-specific differences. J Gen Virol. 71:2747-53. Mathys, A., Mueller. R, Pedersen. N. C, and Theilen. G. H. 1983. Comparison of hemagglutination and competitive enzyme-linked immunosorbent assay procedures for detecting canine parvovirus in feces. Am J Vet Res. 44:152-4. Mathys, A., Mueller. R, Pedersen. N. C, and Theilen. G. H. 1983. Hemagglutination with formalin-fixed erythrocytes for detection of canine parvovirus. Am J Vet Res. 44:150-1. Mc, Candlish. I. A., Thompson. H, Cornwell. H. J, Laird. H, and Wright. N. G. 1979. Isolation of a parvovirus from dogs in Britain. Vet Rec.105:167-8. Mech, L. D., Kurtz. H. J, and Goyal. S. 1997. Death of a wild wolf from canine parvoviral enteritis. J Wildl Dis. 33:321-2. Mildbrand, M. M., Teramoto. Y. A, Collins. J. K, Mathys. A, and Winston. S. 1984. Rapid detection of canine parvovirus in feces using monoclonal antibodies and enzyme-linked immunosorbent assay. Am J Vet Res. 45:2281-4. Minagawa, T., Ishiwata. K, and Kajimoto. T. 1999. Feline interferon-omega treatment on canine parvovirus infection. Vet Microbiol. 69:51-3. Mochizuki, M., Horiuchi. M, Hiragi. H, San. Gabriel. M. C, Yasuda. N, and Uno. T. 1996. Isolation of canine parvovirus from a cat manifesting clinical signs of feline panleukopenia. J Clin Microbiol. 34:2101-5. Mochizuki, M., San. Gabriel. M. C, Nakatani. H, Yoshida. M, and Harasawa. R. 1993. Comparison of polymerase chain reaction with virus isolation and haemagglutination assays for the detection of canine parvoviruses in faecal specimens. Res Vet Sci. 55:60-3. Parker, J. S. L., and Parrish, C. R. 1997. Canine parvovirus host range is determined by the specific conformation of an additional region of the capsid. J. Virol. 71: 9214-9222. Parrish, C. R. 1995. Pathogenesis of feline panleukopenia virus and canine parvovirus. Baillieres Clin Haematol. 8:57-71. Parrish, C. R. 1999. Host range relationships and the evolution of canine parvovirus. Vet.Microbiol. 69:29-40. Parrish, C. R., Aquadro. C. F, Strassheim. M. L, Evermann. J. F, Sgro. J. Y, and Mohammed. H. O. 1991. Rapid antigenic-type replacement and DNA sequence evolution of canine parvovirus. J Virol. 65:6544-52. Parrish, C. R., Have. P, Foreyt. W. J, Evermann. J. F, Senda. M, and Carmichael. L. E. 1988. The global spread and replacement of canine parvovirus strains. J Gen Virol. 69:1111-6. Parrish, C. R., and Kawaoka. Y. 2005. The origins of new pandemic viruses: the acquisition of new host ranges by canine parvovirus and influenza A viruses. Annu Rev Microbiol. 59:553-86. Parrish, C. R., O''Connell. P. H, Evermann. J. F, and Carmichael. L. E. 1985. Natural variation of canine parvovirus. Science. 230:1046-8. Pletcher, J. M., Toft. J. D 2nd, Frey. R. M, and Casey. H. W. 1979. Histopathologic evidence for parvovirus infection in dogs. J Am Vet Med Assoc. 175:825-8. Pollock, R. V., Carmichael. L. E. 1982. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines. Cornell Vet. 72:16-35. Carmichael, L. E., Joubert. J. C, Pollock. R. V. 1983. A modified live canine parvovirus vaccine. II. Immune response. Cornell Vet. 73:13-29. Reed, A. P., Jones. E. V, Miller. T. J. 1988. Nucleotide sequence and genome organization of canine parvovirus. J Virol. 62:266-76. Rhode, S. L 3rd. 1985. Nucleotide sequence of the coat protein gene of canine parvovirus. J Virol. 54:630-3. Rimmelzwaan, G. F., Carlson. J, UytdeHaag. F. G, and Osterhaus. A. D. 1990. A synthetic peptide derived from the amino acid sequence of canine parvovirus structural proteins which defines a B cell epitope and elicits antiviral antibody in BALB c mice. J Gen Virol. 71:2741-5. Rimmelzwaan, G. F., Poelen. M. C, Meloen. R. H, Carlson. J, UytdeHaag. F. G, and Osterhaus. A. D. 1990. Delineation of canine parvovirus T cell epitopes with peripheral blood mononuclear cells and T cell clones from immunized dogs.. J Gen Virol. 71:2321-9. Rimmelzwaan, G. F., van der Heijden. R. W, Tijhaar. E, Poelen. M. C, Carlson. J, Osterhaus. A. D, and UytdeHaag. F. G. 1990. Establishment and characterization of canine parvovirus-specific murine CD4+ T cell clones and their use for the delineation of T cell epitopes. J Gen Virol. 71:1095-102. Robinson, W. F., Wilcox. G. E, Flower. and R. L. 1980. Canine parvoviral disease: experimental reproduction of the enteric form with a parvovirus isolated from a case of myocarditis. Vet Pathol. 17:589-99. Saliki, J. T., Mizak. B, Flore. H. P, Gettig. R. R, Burand. J. P, Carmichael. L. E, Wood. H. A, and Parrish. C. R. 1992. Canine parvovirus empty capsids produced by expression in a baculovirus vector: use in analysis of viral properties and immunization of dogs. J Gen Virol. 73:369-74. Schunck, B., Kraft. W, and Truyen. U. 1995. A simple touch-down polymerase chain reaction for the detection of canine parvovirus and feline panleukopenia virus in feces. J Virol Methods. 55:427-33. Senda, M., Parrish. C. R, Harasawa. R, Gamoh. K, Muramatsu. M, Hirayama. N, and Itoh. O. 1995. Detection by PCR of wild-type canine parvovirus which contaminates dog vaccines. J Clin Microbiol. 33:110-3. Senda, M., Hirayama. N, Yamamoto. H, and Kurata. K. 1986.An improved hemagglutination test for study of canine parvovirus. Vet Microbiol. 12:1-6. Shackelton, L. A., Parrish. C. R , Truyen. U, and Holmen. E. C. 2005. High rate of viral evolution associated with the emergence of carnivore parvovirus. Proc. Nat. Acad. Sci. 102:379-384. Steinel, A., Munson. L, van Vuuren. M, and Truyen. U. 2000. Genetic characterization of feline parvovirus sequences from various carnivores. J. Gen. Virol. 81:345–350. Strassheim, M.L., Gruenberg. A, Veijalainen. P, Sgro. J. Y, and Parrish. C. R. 1994. Two dominant neutralizing antigenic determinants of canine parvovirus are found on the threefold spike of the virus capsid. Virology. 198:175-84. Surleraux, M., and Burtonboy. G. 1984. Structural polypeptides of a canine parvovirus: study by immunoadsorption and sequential analysis of infected cells. Brief report. Arch Virol. 82:233-40. Surleraux, M., Bodeus. M, and Burtonboy. G. 1987. Study of canine parvovirus polypeptides by immunoblot analysis. Arch Virol. 95:271-81. Tateyama, S., Priosoeryanto. B. P, Yamaguchi. R, Uchida. K, Ogiwara. K, and Suchiya. A. T.1995. In vitro growth inhibition activities of recombinant feline interferon on all lines derived from canine tumours. Res Vet Sci. 59:275-7. Thomas, N. J., Foreyt. W. J, Evermann. J. F, Windberg. L. A, and Knowlton. F. F. 1984. Seroprevalence of canine parvovirus in wild coyotes from Texas, Utah, and Idaho (1972 to 1983). J Am Vet Med Assoc. 185:1283-7. Truyen, U., Evermann. J. F, Vieler. E, and Parrish. C. R. 1996. Evolution of canine parvovirus involved loss and gain of feline host range. Virology. 215:186-9. Tsao, J., Chapman. M. S, Agbandje. M, Keller. W, Smith. K, Wu. H, Luo. M, Smith. T. J, Rossmann. M. G, and Compans. R. W. 1991. The three-dimensional structure of canine parvovirus and its functional implications. Science. 251:1456-64. Uwatoko, K., Sunairi. M, Yamamoto. A, Nakajima. M, and Yamaura. K. 1996. Rapid and efficient method to eliminate substances inhibitory to the polymerase chain reaction from animal fecal samples. Vet Microbiol. 52:73-9. Uwatoko, K., Sunairi. M, Nakajima. M, and Yamaura. K. 1995. Rapid method utilizing the polymerase chain reaction for detection of canine parvovirus in feces of diarrheic dogs. Vet Microbiol. 43:315-23. Vihinen-Ranta M., Kalela. A, Makinen. P, Kakkola. L, Marjomaki. V, and Vuento. M. 1998. Intracellular route of canine parvovirus entry. J Virol. 72:802-6. Wang, H.C., Chen. W. D, Lin. S. L, Chan. J. P, and Wong. M. L 2005. Phylogenetic analysis of canine parvovirus VP2 gene in Taiwan. .Virus Genes 31:171–174. Wierup, M., Olson. P, Hedhammar. A, Klingeborn. B, and Karlsson. K. A. 1982. Evaluation of a killed feline panleukopenia virus vaccine against canine parvoviral enteritis in dogs. Am J Vet Res. 43:2183-7. Wu, H., and Rossmann. M. G. 1993. The canine parvovirus empty capsid structure. J Mol Biol. 233:231-44. Zarnke, R. L., Gamble. R, Heckert. R. A, and Ver Hoef. J. 1997. Serologic survey for Trichinella spp. in grizzly bears from Alaska. J Wildl Dis. 33:474-9.
摘要: 犬小病毒 (canine parvovirus, CPV) 屬於小病毒科 (Parvoviridae),具有正20面體直徑約25 nm的蛋白鞘 (capsid)、不具外套膜 (non-enveloped) 。病毒為線性單股DNA (single-stranded DNA) 基因體長度約5.2 kb。CPV主要感染犬科動物,造成新生幼犬心肌炎與出血性腸炎。依學者研究指出,CPV的結構蛋白鞘是由VP1、VP2以及VP3所組成,VP2為其主要蛋白,並且和宿主的免疫反應有重要相關。本實驗材料為來自中興大學獸醫教學醫院的臨床病犬糞材,抽取糞材內CPV的DNA所建構的重組pGEM-VP1/VP2質體,並參考實驗室在GenBank登錄的犬小病毒VP2全長基因序列 (編號AY869724),設計一對引子,利用聚合酶連鎖反應 (PCR) 增幅病毒VP2的核甘酸片段。此片段經適當的限制酵素剪接後,轉接到pET-32b (Novagen) 原核表現載體上,成為pET32b-VP2質體,藉由大腸桿菌BL21 (DE3) 進行VP2全長基因片段的蛋白質表現。經SDS-PAGE分析,可以觀察到如預期大小的VP2蛋白質之表現,並利用西方墨點法 (Western blot) 與質譜儀分析鑑定重組蛋白,結果與預期符合。此外,我們進一步建構pET32b-VP2-1225與pET32b-VP2-1000二個重組質體,以表現C端缺損 (deletion) 的VP2重組蛋白。與全長VP2蛋白相較,此缺損VP2重組蛋白有較佳的表現量。最後利用親合性樹脂管柱,我們已順利地純化全長以及C端缺損的VP2蛋白質。
Canine parvovirus (CPV) is a non-enveloped virus with a single-stranded DNA genome and causes severe enteritis in dog of all ages and myocarditis in puppies. The CPV capsid contains two overlapping proteins, VP1 (82 kDa) and VP2 (65 kDa),. VP3 (63 kDa) is produced by proteolytic processing of VP2. VP2, the most abundant protein of the CPV capsid, seemed to contain all the neutralization sites for host immunity reaction. In this study, a full-length gene of VP2 was cloned into the plasmid pET-32b, expressed in E. coli system, and the recombinant VP2 was purified by affinity chromatography. The recombinant VP2 protein was identified with Western blotting and mass spectrometry analysis. In addition, two recombinant VP2 proteins with C terminal deletions were constructed and expressed. The characterization of these two deletion mutant proteins was performed with techniques used for the full-length VP2. Our results showed that the protein expression level of the VP2 deletion mutant is higher than that of full-length VP2.
URI: http://hdl.handle.net/11455/13276
其他識別: U0005-2408200619065500
文章連結: http://www.airitilibrary.com/Publication/alDetailedMesh1?DocID=U0005-2408200619065500
Appears in Collections:獸醫學系所

文件中的檔案:

取得全文請前往華藝線上圖書館



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.